These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1974565)

  • 41. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8+ suppressor T cell clone capable of inhibiting the antigen- and anti-T cell receptor-induced proliferation of Th clones without cytolytic activity.
    Hisatsune T; Enomoto A; Nishijima K; Minai Y; Asano Y; Tada T; Kaminogawa S
    J Immunol; 1990 Oct; 145(8):2421-6. PubMed ID: 1976694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigen-specific and antibody-mediated growth inhibition of suppressor T cell hybridomas. Roles of H-2 and the CD3-T cell receptor-alpha/beta complex.
    Kuchroo VK; Billings PR; Levine C; Martin CA; Kubo RT; Dorf ME
    J Immunol; 1990 Aug; 145(4):1059-65. PubMed ID: 2143205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerance and immunity to the inducible self antigen C-reactive protein in transgenic mice.
    Klein TC; Döffinger R; Pepys MB; Rüther U; Kyewski B
    Eur J Immunol; 1995 Dec; 25(12):3489-95. PubMed ID: 8566042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell immunity or tolerance as a consequence of self antigen presentation.
    Lin RH; Stockinger B
    Eur J Immunol; 1989 Jan; 19(1):105-10. PubMed ID: 2784102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation.
    Via CS; Tsokos GC; Stocks NI; Clerici M; Shearer GM
    J Immunol; 1990 Apr; 144(7):2524-8. PubMed ID: 1969449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional consequences of overexpressed Ia antigens in AK alpha/AK beta transgenic mice.
    Fehling HJ; van Ewijk W; Pasquali JL; Waltzinger C; Le Meur M; Gerlinger P; Benoist C; Mathis D
    J Immunol; 1990 Apr; 144(8):2865-74. PubMed ID: 1969873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Partial tolerance in beta-galactosidase-transgenic mice.
    Theopold U; Köhler G
    Eur J Immunol; 1990 Jun; 20(6):1311-6. PubMed ID: 2114998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The specific interaction of helper T cells and antigen-presenting B cells. IV. Membrane and cytoskeletal reorganizations in the bound T cell as a function of antigen dose.
    Kupfer A; Singer SJ
    J Exp Med; 1989 Nov; 170(5):1697-713. PubMed ID: 2530300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cells solicit their own help from T cells.
    Stockinger B; Zal T; Zal A; Gray D
    J Exp Med; 1996 Mar; 183(3):891-9. PubMed ID: 8642293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of in vivo monoclonal anti-I-A antibody treatment in neonatal mice on intrathymic and peripheral class II antigen expression.
    Williams WW; Falo LD; Lu CY; Benacerraf B; Sy MS
    Cell Immunol; 1988 Jan; 111(1):126-38. PubMed ID: 2827892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photoaffinity labeling demonstrates binding between Ia molecules and nominal antigen on antigen-presenting cells.
    Phillips ML; Yip CC; Shevach EM; Delovitch TL
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5634-8. PubMed ID: 2942939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
    Lewis TA; Munson AE; McCoy KL
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How the immune system learns about self.
    von Boehmer H; Kisielow P
    Sci Am; 1991 Oct; 265(4):74-81. PubMed ID: 1836069
    [No Abstract]   [Full Text] [Related]  

  • 55. Peripheral tolerance in transgenic mice: tolerance to class II MHC and non-MHC transgene antigens.
    Lo D; Freedman J; Hesse S; Brinster RL; Sherman L
    Immunol Rev; 1991 Aug; 122():87-102. PubMed ID: 1682240
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression of CD3-associated antigen-binding receptors on suppressor T cells.
    Kuchroo VK; Steele JK; Billings PR; Selvaraj P; Dorf ME
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9209-13. PubMed ID: 2973609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerance induced by physiological levels of secreted proteins in transgenic mice expressing human insulin.
    Whiteley PJ; Lake JP; Selden RF; Kapp JA
    J Clin Invest; 1989 Nov; 84(5):1550-4. PubMed ID: 2681269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells.
    Lo D; Burkly LC; Flavell RA; Palmiter RD; Brinster RL
    J Exp Med; 1989 Jul; 170(1):87-104. PubMed ID: 2526197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory mechanisms of the immune response to heterologous insulins. I. Development and regulation of plaque-forming cell responses in vitro.
    Jensen PE; Kapp JA
    Cell Immunol; 1984 Aug; 87(1):73-84. PubMed ID: 6204779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD4 T cells and their role in antitumor immune responses.
    Toes RE; Ossendorp F; Offringa R; Melief CJ
    J Exp Med; 1999 Mar; 189(5):753-6. PubMed ID: 10049938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.